Behavioral health company LifeStance Health (NASDAQ:LFST) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 21.2% year on...
What Happened? Shares of behavioral health company LifeStance Health (NASDAQ:LFST) jumped 15.4% in the afternoon session after the company reported strong fi...
Behavioral health company LifeStance Health (NASDAQ:LFST) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 21.2% year on year to $403.5 mi...
Behavioral health company LifeStance Health (NASDAQ:LFST) will be announcing earnings results this Thursday before market hours. Here’s what you need to know...
Check out the companies making headlines yesterday: Commvault (NASDAQ:CVLT): Data protection software company Commvault (NASDAQ:CVLT) rose by 10.7% on Tuesda...
What Happened? Shares of behavioral health company LifeStance Health (NASDAQ:LFST) jumped 5% in the afternoon session after S&P Dow Jones Indices announced t...
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic...
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking a...
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,...
What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in...
On this Tuesday, March 24, 2026, the healthcare sector is witnessing a dramatic rally in shares of LifeStance Health Group, Inc. (NASDAQ: LFST). The stock is surging double digits in early trading following a high-conviction upgrade from a tier-one investment bank, marking a definitive turning point for a company that was once the poster child [...]
Over the past six months, LifeStance Health Group has been a great trade, beating the S&P 500 by 22.7%. Its stock price has climbed to $6.58, representing a ...
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry...
Behavioral health company LifeStance Health (NASDAQ:LFST) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 17.4% year on year to $382.2 million. Guidance for next quarter’s revenue was optimistic at $390 million at the midpoint, 2.4% above analysts’ estimates. Its GAAP profit of $0.03 per share was significantly above analysts’ consensus estimates.
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns.
Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
A number of stocks jumped in the afternoon session after a softer-than-expected inflation report fueled hopes for interest rate cuts by the Federal Reserve. The January Consumer Price Index (CPI), a key measure of inflation, rose by 0.2%, which was less than economists had forecast, with the annual rate cooling to 2.4%. This encouraging data increased market expectations for the Fed to begin cutting interest rates as early as June. The news prompted a rally in Treasuries as their yields fell. While the market's reaction was initially described as a "bumpy ride" due to concerns in other sectors, the favorable inflation data ultimately helped calm Wall Street. Lower inflation is a key prerequisite for the central bank to ease its monetary policy, which is generally supportive of stock valuations.
Wall Street has set ambitious price targets for the stocks in this article.
While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street.
Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.
